OncoSec Medical Incorporated Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Cash and Cash Equivalents and Liquidity (Details)

Cash and Cash Equivalents and Liquidity (Details) (USD $)	3 Months Ended		6 Months Ended		84 Months Ended
	Jan. 31, 2015	Jan. 31, 2014	Jan. 31, 2015	Jan. 31, 2014	Jan. 31, 2015	Jul. 31, 2014	Jul. 31, 2013
Cash and Cash Equivalents and Liquidity
Losses in all previous reporting periods from inception to date	$ 4,618,237	$ 2,600,429	$ 8,679,353	$ 4,651,915	$ 34,000,000
Cash and cash equivalents	$ 30,699,218	$ 18,450,070	$ 30,699,218	$ 18,450,070	$ 30,699,218	$ 37,852,694	$ 4,970,175

- Definition

Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.

+ References + Details